In a recent decision, the United States Court of Federal Claims dismissed a vaccine injury claim filed by Edward Torres. The court ruled that Torres did not provide enough evidence to support his assertion that the pneumococcal conjugate vaccine caused him to develop Guillain-Barré syndrome (GBS). This ruling affects Torres and others seeking compensation under the National Vaccine Injury Compensation Program.
The case, Torres v. Secretary of Health and Human Services, was filed on October 21, 2025, after Torres alleged that the Prevnar 20 vaccine he received on May 25, 2024, led to his diagnosis of GBS. The decision is significant as it highlights the challenges petitioners face in proving vaccine-related injuries.
Background
Edward Torres is the petitioner in this case, claiming that he suffered from GBS as a result of receiving the Prevnar 20 vaccine. The Secretary of Health and Human Services is the respondent, representing the government's position on vaccine injury claims. The case was filed in the Office of Special Masters within the United States Court of Federal Claims, which handles vaccine-related injury claims.
After filing his petition, Torres submitted medical records and a statement of completion by November 20, 2025. However, the case faced complications when the court noted a previous decision that denied compensation for a similar claim involving the Prevnar-13 vaccine and GBS. This earlier ruling raised concerns about the likelihood of success for Torres's claim.
The Ruling
On July 31, 2026, Torres filed a motion to dismiss his petition, acknowledging that his treating physician had determined that his most probable diagnosis was Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) rather than GBS. The court, presided over by Special Master Christian J. Moran, found that Torres did not submit an expert report to support his claim that the vaccine caused his condition.
The court ruled, "there is insufficient evidence to support a finding of vaccine-causation."
Due to the lack of evidence, the court dismissed the case with prejudice, meaning Torres cannot refile the same claim in the future. The ruling emphasized the need for petitioners to provide credible medical evidence to substantiate their claims under the National Vaccine Injury Compensation Program.
Impact
This ruling has implications for others who may seek compensation for vaccine-related injuries. It underscores the importance of having strong medical evidence and expert testimony to support claims. The decision may deter some potential petitioners from pursuing similar claims, knowing the high burden of proof required.
Furthermore, the court's reference to previous cases, such as Romine v. Secretary of Health and Human Services and Gamboa-Avila v. Secretary of Health and Human Services, indicates that the legal landscape for vaccine injury claims is evolving. The court's decisions in these cases suggest a cautious approach to claims involving vaccines and GBS.
What's Next
Torres's case cannot be appealed due to the dismissal with prejudice. There are no related cases pending that were mentioned in the court filing. However, the outcome of this case may influence future claims made under the National Vaccine Injury Compensation Program.